ERBB2 and thyroid cancer: Comprehensive molecular analysis of canine thyroid cancer (TC) uncovers distinct oncogenic pathways: ERBB2/HER2 activation in follicular TC, and RET signaling in medullary TC, mirroring human TC and highlighting species-specific mechanisms.